PARP1 and neuroblastoma: Lee et al. have reported that, though a PARP-1-targeted Auger emitter 125I-KX1 was highly cytotoxic in vitro, it was predicted to display limited therapeutic efficacy in solid tumor models of neuroblastoma [39].